Home / Drug shortages / Sodium Acetate Injection

Sodium Acetate Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Sodium Acetate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 02/03/2016. Reported reason: Demand increase for the drug

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-6261-01
Dosage Form
Injection
Presentation
Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01)
Initial Posting
02/03/2016
Revised Date

Reason

Demand increase for the drug

FDA data resources